Loading
We have very little insider data for Immunotechnology Corp so far: the most recent filing dates from 15 December 2006. With so few records, no pattern can be drawn yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
4 of 4 declarations
Immunotechnology Corp is a publicly traded company on NASDAQ, specializing in the development of innovative biotechnology solutions. It focuses on research and commercialization of products related to immune health.